ID   MEX3B_HUMAN             Reviewed;         569 AA.
AC   Q6ZN04; Q4G0W1; Q8IVG2; Q9H0J0;
DT   06-MAR-2007, integrated into UniProtKB/Swiss-Prot.
DT   05-JUL-2004, sequence version 1.
DT   18-JUN-2025, entry version 170.
DE   RecName: Full=RNA-binding protein MEX3B;
DE   AltName: Full=RING finger and KH domain-containing protein 3;
DE   AltName: Full=RING finger protein 195;
GN   Name=MEX3B; Synonyms=KIAA2009, RKHD3, RNF195;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), TISSUE SPECIFICITY,
RP   PHOSPHORYLATION, AND MUTAGENESIS OF GLY-177.
RX   PubMed=17267406; DOI=10.1093/nar/gkm016;
RA   Buchet-Poyau K., Courchet J., Le Hir H., Seraphin B., Scoazec J.-Y.,
RA   Duret L., Domon-Dell C., Freund J.-N., Billaud M.;
RT   "Identification and characterization of human Mex-3 proteins, a novel
RT   family of evolutionarily conserved RNA-binding proteins differentially
RT   localized to processing bodies.";
RL   Nucleic Acids Res. 35:1289-1300(2007).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Brain;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Brain;
RA   Nagase T., Kikuno R., Ohara O.;
RT   "The nucleotide sequence of a long cDNA clone isolated from human.";
RL   Submitted (NOV-2002) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Brain, and Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 304-569.
RC   TISSUE=Testis;
RX   PubMed=11230166; DOI=10.1101/gr.gr1547r;
RA   Wiemann S., Weil B., Wellenreuther R., Gassenhuber J., Glassl S.,
RA   Ansorge W., Boecher M., Bloecker H., Bauersachs S., Blum H., Lauber J.,
RA   Duesterhoeft A., Beyer A., Koehrer K., Strack N., Mewes H.-W.,
RA   Ottenwaelder B., Obermaier B., Tampe J., Heubner D., Wambutt R., Korn B.,
RA   Klein M., Poustka A.;
RT   "Towards a catalog of human genes and proteins: sequencing and analysis of
RT   500 novel complete protein coding human cDNAs.";
RL   Genome Res. 11:422-435(2001).
RN   [6]
RP   PHOSPHORYLATION AT SER-462, AND SUBCELLULAR LOCATION.
RX   PubMed=18779327; DOI=10.1074/jbc.m802927200;
RA   Courchet J., Buchet-Poyau K., Potemski A., Bres A., Jariel-Encontre I.,
RA   Billaud M.;
RT   "Interaction with 14-3-3 adaptors regulates the sorting of hMex-3B RNA-
RT   binding protein to distinct classes of RNA granules.";
RL   J. Biol. Chem. 283:32131-32142(2008).
RN   [7]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-4 AND SER-288, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
CC   -!- FUNCTION: RNA-binding protein. May be involved in post-transcriptional
CC       regulatory mechanisms.
CC   -!- INTERACTION:
CC       Q6ZN04; P62258: YWHAE; NbExp=2; IntAct=EBI-722315, EBI-356498;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:18779327}. Cytoplasm
CC       {ECO:0000269|PubMed:18779327}. Cytoplasm, P-body
CC       {ECO:0000269|PubMed:18779327}. Cytoplasmic granule
CC       {ECO:0000269|PubMed:18779327}. Note=Predominantly expressed in the
CC       cytoplasm and shuttles between the cytoplasm and the nucleus through
CC       the CRM1 export pathway. Localization to P-bodies is dependent on 14-3-
CC       3.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q6ZN04-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q6ZN04-3; Sequence=VSP_041891, VSP_041892;
CC   -!- TISSUE SPECIFICITY: Highest levels found in fetal brain and testis.
CC       Detected in the adult intestinal epithelium, specifically in goblet
CC       cell at protein level. {ECO:0000269|PubMed:17267406}.
CC   -!- DOMAIN: Binds RNA through its KH domains.
CC   -!- PTM: Phosphorylation at Ser-462 creates a docking site for 14-3-3,
CC       which stabilizes the protein and modulates its ability to bind RNA.
CC       {ECO:0000269|PubMed:17267406, ECO:0000269|PubMed:18779327}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAC23105.1; Type=Erroneous translation; Note=Wrong choice of CDS.; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AY950678; AAY34146.1; -; mRNA.
DR   EMBL; AK131424; BAD18571.1; -; mRNA.
DR   EMBL; AB095929; BAC23105.1; ALT_SEQ; mRNA.
DR   EMBL; BC036211; AAH36211.1; -; mRNA.
DR   EMBL; BC111545; AAI11546.1; -; mRNA.
DR   EMBL; AL136778; CAB66712.2; -; mRNA.
DR   CCDS; CCDS10319.1; -. [Q6ZN04-1]
DR   RefSeq; NP_115622.2; NM_032246.4. [Q6ZN04-1]
DR   AlphaFoldDB; Q6ZN04; -.
DR   SMR; Q6ZN04; -.
DR   BioGRID; 123945; 220.
DR   FunCoup; Q6ZN04; 1696.
DR   IntAct; Q6ZN04; 13.
DR   MINT; Q6ZN04; -.
DR   STRING; 9606.ENSP00000329918; -.
DR   GlyGen; Q6ZN04; 4 sites, 1 N-linked glycan (1 site), 1 O-linked glycan (1 site).
DR   iPTMnet; Q6ZN04; -.
DR   PhosphoSitePlus; Q6ZN04; -.
DR   BioMuta; MEX3B; -.
DR   DMDM; 74762391; -.
DR   jPOST; Q6ZN04; -.
DR   MassIVE; Q6ZN04; -.
DR   PaxDb; 9606-ENSP00000329918; -.
DR   PeptideAtlas; Q6ZN04; -.
DR   ProteomicsDB; 67950; -. [Q6ZN04-1]
DR   ProteomicsDB; 67951; -. [Q6ZN04-3]
DR   Pumba; Q6ZN04; -.
DR   Antibodypedia; 28006; 107 antibodies from 26 providers.
DR   DNASU; 84206; -.
DR   Ensembl; ENST00000329713.5; ENSP00000329918.4; ENSG00000183496.6. [Q6ZN04-1]
DR   Ensembl; ENST00000558133.1; ENSP00000456938.1; ENSG00000183496.6. [Q6ZN04-3]
DR   GeneID; 84206; -.
DR   KEGG; hsa:84206; -.
DR   MANE-Select; ENST00000329713.5; ENSP00000329918.4; NM_032246.6; NP_115622.2.
DR   UCSC; uc002bgq.3; human. [Q6ZN04-1]
DR   AGR; HGNC:25297; -.
DR   CTD; 84206; -.
DR   DisGeNET; 84206; -.
DR   GeneCards; MEX3B; -.
DR   HGNC; HGNC:25297; MEX3B.
DR   HPA; ENSG00000183496; Group enriched (cervix, testis).
DR   MIM; 611008; gene.
DR   OpenTargets; ENSG00000183496; -.
DR   VEuPathDB; HostDB:ENSG00000183496; -.
DR   eggNOG; KOG2113; Eukaryota.
DR   GeneTree; ENSGT00940000160013; -.
DR   HOGENOM; CLU_025598_2_0_1; -.
DR   InParanoid; Q6ZN04; -.
DR   OMA; QFERGPA; -.
DR   OrthoDB; 427410at2759; -.
DR   PAN-GO; Q6ZN04; 0 GO annotations based on evolutionary models.
DR   PhylomeDB; Q6ZN04; -.
DR   PathwayCommons; Q6ZN04; -.
DR   SignaLink; Q6ZN04; -.
DR   SIGNOR; Q6ZN04; -.
DR   BioGRID-ORCS; 84206; 18 hits in 1165 CRISPR screens.
DR   CD-CODE; 232F8A39; P-body.
DR   CD-CODE; CA00D4B7; MEX3B granule.
DR   CD-CODE; DEE660B4; Stress granule.
DR   GeneWiki; MEX3B; -.
DR   GenomeRNAi; 84206; -.
DR   Pharos; Q6ZN04; Tbio.
DR   PRO; PR:Q6ZN04; -.
DR   Proteomes; UP000005640; Chromosome 15.
DR   RNAct; Q6ZN04; protein.
DR   Bgee; ENSG00000183496; Expressed in sperm and 103 other cell types or tissues.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0000932; C:P-body; IDA:UniProtKB.
DR   GO; GO:0005509; F:calcium ion binding; ISS:UniProtKB.
DR   GO; GO:0003723; F:RNA binding; IDA:UniProtKB.
DR   GO; GO:0008270; F:zinc ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0046777; P:protein autophosphorylation; ISS:UniProtKB.
DR   GO; GO:0006468; P:protein phosphorylation; ISS:UniProtKB.
DR   CDD; cd22423; KH-I_MEX3_rpt1; 1.
DR   CDD; cd22424; KH-I_MEX3_rpt2; 1.
DR   CDD; cd16721; RING-HC_MEX3B; 1.
DR   FunFam; 3.30.1370.10:FF:000013; Mex-3 RNA-binding family member B; 1.
DR   FunFam; 3.30.40.10:FF:000090; Mex-3 RNA-binding family member C; 1.
DR   FunFam; 3.30.1370.10:FF:000012; Mex-3 RNA-binding family member D; 1.
DR   Gene3D; 3.30.1370.10; K Homology domain, type 1; 2.
DR   Gene3D; 3.30.40.10; Zinc/RING finger domain, C3HC4 (zinc finger); 1.
DR   InterPro; IPR047228; KH-I_MEX3_rpt1.
DR   InterPro; IPR047226; KH-I_MEX3_rpt2.
DR   InterPro; IPR004087; KH_dom.
DR   InterPro; IPR004088; KH_dom_type_1.
DR   InterPro; IPR036612; KH_dom_type_1_sf.
DR   InterPro; IPR047227; MEX3.
DR   InterPro; IPR001841; Znf_RING.
DR   InterPro; IPR013083; Znf_RING/FYVE/PHD.
DR   PANTHER; PTHR23285; RING FINGER AND KH DOMAIN CONTAINING PROTEIN 1; 1.
DR   PANTHER; PTHR23285:SF5; RNA-BINDING PROTEIN MEX3B; 1.
DR   Pfam; PF00013; KH_1; 2.
DR   Pfam; PF13920; zf-C3HC4_3; 1.
DR   SMART; SM00322; KH; 2.
DR   SMART; SM00184; RING; 1.
DR   SUPFAM; SSF54791; Eukaryotic type KH-domain (KH-domain type I); 2.
DR   SUPFAM; SSF57850; RING/U-box; 1.
DR   PROSITE; PS50084; KH_TYPE_1; 2.
DR   PROSITE; PS50089; ZF_RING_2; 1.
DR   neXtProt; NX_Q6ZN04; -.
DR   PharmGKB; PA162395820; -.
DR   TreeFam; TF315107; -.
PE   1: Evidence at protein level;
KW   Alternative splicing; Cytoplasm; Metal-binding; Nucleus; Phosphoprotein;
KW   Proteomics identification; Reference proteome; Repeat; RNA-binding; Zinc;
KW   Zinc-finger.
FT   CHAIN           1..569
FT                   /note="RNA-binding protein MEX3B"
FT                   /id="PRO_0000278784"
FT   DOMAIN          66..127
FT                   /note="KH 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00117"
FT   DOMAIN          160..221
FT                   /note="KH 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00117"
FT   ZN_FING         518..558
FT                   /note="RING-type"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00175"
FT   REGION          1..31
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          252..296
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          338..365
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          482..514
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        13..26
FT                   /note="Gly residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        491..509
FT                   /note="Low complexity"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         4
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         288
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         462
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000269|PubMed:18779327"
FT   VAR_SEQ         87..158
FT                   /note="CKIKALRAKTNTYIKTPVRGEEPVFVVTGRKEDVAMARREIISAAEHFSMIR
FT                   ASRNKNTALNGAVPGPPNLP -> RSRRDGEVGGGGVGSQATASRGRRVQYRDPRRGVP
FT                   WGERKSRAMGRRPRQRKCRQAVSRSRAAALAGCTFFC (in isoform 2)"
FT                   /evidence="ECO:0000303|Ref.3"
FT                   /id="VSP_041891"
FT   VAR_SEQ         159..569
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|Ref.3"
FT                   /id="VSP_041892"
FT   MUTAGEN         177
FT                   /note="G->D: Prevents RNA binding."
FT                   /evidence="ECO:0000269|PubMed:17267406"
FT   CONFLICT        414
FT                   /note="G -> S (in Ref. 4; AAH36211)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        536
FT                   /note="N -> S (in Ref. 4; AAH36211)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   569 AA;  58832 MW;  DA5D014C4D8E1BB8 CRC64;
     MPSSLFADLE RNGSGGGGGG SSGGGETLDD QRALQLALDQ LSLLGLDSDE GASLYDSEPR
     KKSVNMTECV PVPSSEHVAE IVGRQGCKIK ALRAKTNTYI KTPVRGEEPV FVVTGRKEDV
     AMARREIISA AEHFSMIRAS RNKNTALNGA VPGPPNLPGQ TTIQVRVPYR VVGLVVGPKG
     ATIKRIQQQT HTYIVTPSRD KEPVFEVTGM PENVDRAREE IEAHIALRTG GIIELTDEND
     FHANGTDVGF DLHHGSGGSG PGSLWSKPTP SITPTPGRKP FSSYRNDSSS SLGSASTDSY
     FGGGTSSSAA ATQRLADYSP PSPALSFAHN GNNNNNGNGY TYTAGGEASV PSPDGCPELQ
     PTFDPAPAPP PGAPLIWAQF ERSPGGGPAA PVSSSCSSSA SSSASSSSVV FPGGGASAPS
     NANLGLLVHR RLHPGTSCPR LSPPLHMAPG AGEHHLARRV RSDPGGGGLA YAAYANGLGA
     QLPGLQPSDT SGSSSSSSSS SSSSSSSSGL RRKGSRDCSV CFESEVIAAL VPCGHNLFCM
     ECANRICEKS EPECPVCHTA VTQAIRIFS
//
